Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
883
-
Total shares
-
43.3M
-
Shares change
-
+4.96M
-
Total reported value, excl. options
-
$5.68B
-
Value change
-
+$657M
-
Put/Call ratio
-
1.57
-
Number of buys
-
336
-
Number of sells
-
-318
-
Price
-
$131.29
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2022
902 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2022.
ISHARES TR - ISHARES BIOTECH (IBB) has 883 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.3M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (9.73M shares), MORGAN STANLEY (3.11M shares), GOLDMAN SACHS GROUP INC (1.87M shares), Royal Bank of Canada (1.83M shares), CITIGROUP INC (1.69M shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (1.55M shares), UBS Group AG (1.47M shares), Caxton Associates LP (1.16M shares), JANE STREET GROUP, LLC (1M shares), and WELLS FARGO & COMPANY/MN (900K shares).
This table shows the top 883 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.